Rapid resolution of suicidal behavior and depression with single low-dose ketamine intravenous push even after 6 months of follow-up

Journal of Clinical Psychopharmacology

Volumn 34, Issue 4, 2014, Pages 533-535

  Aligeti, Sabitha ^a   Quinones, Marlon ^a   Salazar, Ricardo ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEACHING AGENT; CETIRIZINE; DOMESTIC CHEMICAL; HYDROCODONE; KETAMINE; LITHIUM CARBONATE; NON PRESCRIPTION DRUG; OPIATE; PARACETAMOL; SEDATIVE AGENT; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ALCOHOLISM; ANXIETY; BIPOLAR II DISORDER; BIPOLAR INVENTORY OF SIGNS AND SYMPTOMS SCALE; CASE REPORT; CLINICAL ASSESSMENT; CONSULTATION; DECREASED APPETITE; DEPRESSION; DISSOCIATIVE DISORDER; DIVORCE; DRUNKEN DRIVING; ENERGY; EXPECTATION; FATALITY; FOLLOW UP; HAMILTON SCALE; HEMATOTHORAX; HISPANIC; HOPELESSNESS; HOSPITAL ADMISSION; HUMAN; HUMAN RELATION; HYPERTENSION; INGESTION; INTENSIVE CARE; IRRITABILITY; LACERATION; LETTER; LOW DRUG DOSE; MALE; MANIA; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NECK; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; REMISSION; SINGLE DRUG DOSE; SLEEP DISORDER; STAB WOUND; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE ATTEMPT; SYMPTOM ASSESSMENT; TACHYCARDIA; THORAX; WRIST; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; PSYCHOLOGY; TIME;

ADULT; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; KETAMINE; MALE; SUICIDAL IDEATION; TIME FACTORS;

EID: 84903707853     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000146     Document Type: Letter

References (16)

1. WHO: Depression, Media Centre, World Health Organization, 2012. Available at: http://www.who.int/mediacentre/factsheets/ fs369/en/. Accessed October 5, 2013.
2. Petronis KR, Samuels JF, Moscicki EK, et al. An epidemiologic investigation of potential risk factors for suicide attempts. Soc Psychiatry Psychiatr Epidemiol. 1990;25:193-199. (Pubitemid 20244312)
3. CDC: Suicide: Facts at a Glance, CDC Web site, CDC: National Center for Injury Prevention and Control, Division of Violence Prevention, 2012. Available at: http:// www.cdc.gov/ViolencePrevention/pdf/ Suicide-DataSheet-a.pdf. Accessed October 5, 2013.
4. Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry. 2000;61(suppl 6):4-6. (Pubitemid 30217404)
5. Autry AE, Adachi M, Nosyreva E, et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature. 2011;475:91-95.
6. Berman RM, Cappiello A, Anand A, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351-354. (Pubitemid 30109248)
7. DiazGranados N, Ibrahim LA, Brutsche NE, et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry. 2010;71:1605-1611.
8. Larkin GL, Beautrais AL. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol. 2011;14:1127-1131.
9. Price RB, Nock MK, Charney DS, et al. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry. 2009;66:522-526.
10. Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012;338:68-72.
11. Duman RS, Li N. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philos Trans R Soc Lond B Biol Sci. 2012;367:2475-2484.
12. Espinosa F, Kavalali ET. NMDA receptor activation by spontaneous glutamatergic neurotransmission. J Neurophysiol. 2009;101:2290-2296.
13. Hoshaw BA, Malberg JE, Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 2005;1037:204-208. (Pubitemid 40362398)
14. Kavalali ET, Monteggia LM. Synaptic mechanisms underlying rapid antidepressant action of ketamine. Am J Psychiatry. 2012;169:1150-1156.
15. McIntyre R, Kennedy S, Bagby RM, et al. Assessing full remission. J Psychiatry Neurosci. 2002;27:235-239. (Pubitemid 34988903)
16. Montgomery SA, AsbergM. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389. (Pubitemid 9136500)